- Home
- IPA vs MIRA Comparison
IPA vs MIRA Comparison
Compare IPA & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPA
- MIRA
- Stock Information
- Founded
- IPA 1983
- MIRA 2020
- Country
- IPA Canada
- MIRA United States
- Employees
- IPA N/A
- MIRA N/A
- Industry
- IPA Biotechnology: Pharmaceutical Preparations
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- IPA Health Care
- MIRA Health Care
- Exchange
- IPA Nasdaq
- MIRA Nasdaq
- Market Cap
- IPA 18.9M
- MIRA 21.2M
- IPO Year
- IPA 2017
- MIRA 2023
- Fundamental
- Price
- IPA $0.44
- MIRA $1.09
- Analyst Decision
- IPA Strong Buy
- MIRA Strong Buy
- Analyst Count
- IPA 2
- MIRA 2
- Target Price
- IPA $5.00
- MIRA $14.00
- AVG Volume (30 Days)
- IPA 297.3K
- MIRA 493.9K
- Earning Date
- IPA 12-10-2024
- MIRA 11-12-2024
- Dividend Yield
- IPA N/A
- MIRA N/A
- EPS Growth
- IPA N/A
- MIRA N/A
- EPS
- IPA N/A
- MIRA N/A
- Revenue
- IPA $17,272,336.00
- MIRA N/A
- Revenue This Year
- IPA $1.88
- MIRA N/A
- Revenue Next Year
- IPA $9.90
- MIRA N/A
- P/E Ratio
- IPA N/A
- MIRA N/A
- Revenue Growth
- IPA 6.36
- MIRA N/A
- 52 Week Low
- IPA $0.33
- MIRA $0.51
- 52 Week High
- IPA $2.60
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- IPA 54.53
- MIRA 37.31
- Support Level
- IPA $0.36
- MIRA $1.04
- Resistance Level
- IPA $0.42
- MIRA $1.16
- Average True Range (ATR)
- IPA 0.04
- MIRA 0.10
- MACD
- IPA 0.01
- MIRA -0.02
- Stochastic Oscillator
- IPA 69.38
- MIRA 24.29
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, Australia and others. The majority of its revenue is derived from United States of America.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.